研究

Kim HS, Song W, Choo W, Lee S, Han Y, Bassi C, Salvia R, Marchegiani G, Wolfgang CL, He J, Blair AB, Kluger MD, Su GH, Kim SC, Song KB, Yamamoto M, Hatori T, Yang CY, Yamaue H, Hirono S, Satoi S, Fujii T, Hirano S, Lou W, Hashimoto Y, Shimizu Y, Del Chiaro M, Valente R, Lohr M, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Shyr YM, Wang SE, Han HS, Yoon YS, Besselink MG, van Huijgevoort NCM, Sho M, Nagano H, Kim SG, Honda G, Yang Y, Yu HC, Do Yang J, Chung JC, Nagakawa Y, Seo HI, Lee S, Kim H, Kwon W, Park T, Jang JY

Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study

Ioka T, Kanai M, Kobayashi S, sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shido Y, Yoshmura K, Hatano E, Nagano H, Kansai Hepatobiliary Oncology Group (KHBO)

Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplation for advanced biliary tract cancer (KHBO1401-MITSUBA)

Asakura Y, Toyama H, Ishida J, Asari S, Terai S, Shirakawa S, Yamashita H, Shimizu T, Ogura Y, Matsumoto I, Gon H, Tsugawa D, Komatsu S, Kuramitsu K, Yanagimoto H, Kido M, Ajiki T, Fukumoto T

Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma

Nanno Y, Toyama H, Matsumoto I, Uemura J, Asari S, Goto T, Lee D, Murakami T, Komatsu S, Yanagimoto H, Kido M, Ajiki T, Okano K, Takeyama Y, Fukumoto T

Reappraisal of malignant risk assessment for small (≤20mm) non-functioning pancreatic neuroendocrine tumors

Lee W, Hwang DW, Han HS, Han IW, Heo JS, Unno M, Ishida M, Tajima H, Nishizawa N, Nakata K, Seyama Y, Ishikawa Y, Hwang HK, Jang JY, Hong T, Park JS, Kim HJ, Jeong CY, Park JI, Matsumoto I, Yamaue H, Kawai M, Ohtsuka M, Mizuno S, Asakuma M, Doejima Y, Hirashita T, Sho M, Takeda Y, Park JI, Kim YH, Kim HJ, Yamaue H, Yamamoto M, Endo I, Nakamura M, Yoon YS

Comparison of infectious complications after spleen preservation versus splenectomy during laparoscopic distal pancreatectomy for benign or low-grade malignant pancreatic tumors: A multicenter, propensity score-matched analysis

Tamura T, Takenaka M, Terai T, Ogura T, Tani M, Shimokawa T, Kitahata Y, Matsumoto I, Mitoro A, Asakuma M, Inatomi O, Omoto S, Sho M; Ueno S, Maehira H, Kitano M

Gastrojejunostomy versus endoscopic duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer: a propensity score-matched analysis

Okusaka T, Nakamura M, Yoshida M, Kitano M, Ito Y, Mizuno N, Hanada K, Ozaka M, Morizane C, Takeyama Y; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society

Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis

Nanno Y, Toyama H, Matsumoto I, Uemura J, Asari S, Goto T, Lee D, Murakami T, Komatsu S, Yanagimoto H, Kido M, Ajiki T, Okano K, Takeyama Y, Fukumoto

ASO Visual Abstract: Reappraisal of Malignant Risk Assessment for Small (≤20mm) Non-functioning Pancreatic Neuroendocrine Tumors

Oba A, Del Chiaro M, Fujii T, Okano K, Stoop TF, Wu YHA, Maekawa A, Yoshida Y, Hashimoto D, Sugawara T, Inoue Y, Tanabe M, Sho M, Sasaki T, Takahashi, Matsumoto I, Sasahira N, Nagakawa Y, Satoi S, Schulik RD, Yoon YS, He J, Jang JY, Wolfgang CL, Hackert T, Besselink MG, Takaori K, Takeyama Y

“Conversion surgery” for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) and Japan pancreas Society (JPS) 2022.

Nakamura T, Okada KI, Ohtsuka M, Higuchi R, Takahashi H, Nagai K, Unno M, Murakami Y, Oba A, Tomikawa M, Kato A, Horiguchi A, Nakamura M, Yagi S, Satoi S, Endo I, Amano R, Matsumoto I, Ito YM, Nagakawa T, Hirano S

Insights from managing clinical issues in distal pancreatectomy with en bloc celiac axis resection: experiences from 626 patients

Hashimoto D, Fujii T, Sho M, He J, Hackert T, Del Chiaro M, Jang JY, Gulla A, Yoon YS, Shan YS, Lou W, Valente R, Furuse J, Oba A, Nagai M, Terai T, Tanaka H, Sakai A, Yamamoto T, Yamaki S, Matsumoto I, Murakami Y, Takaori K, Takeyama Y

Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal metastasis? A postion paper by experts in pancreatic surgery at the Joint Meeting of the International Association of pancreatology (IAP) and the Japan Pancreas Society (JPS) 2022 in Kyoto

Okada K, Kimura K, Yamashita Y, Shibuya K, Matsumoto I, Satoi S, Yosshida K, Kodera Y, Akahori T, Hirono S, Eguchi H, Asakuma M, Tani M, Hatano E, Ikoma H, Ohira G, Hayashi H, Wan K, Shimokawa T, Kawai M, Yamaue H, The NAC-GA investigators

Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial)

Nakamura K, Nagai M, Matsumoto I, Satoi S, Motoi F, Kawai M, Hosouchi Y, Higuchi R, Mizuno S, Ohtsuka T, Akahoshi K, Hakamada K, Unno M, Yamaue H, Nakamura M, Endo I, Sho M

Impact of antithrombotic therapy on postpancreaatectomy hemorrhage in 7116 patients: A project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

Sugiura T, Toyama H, Fukutomi A, Asakura H, Takeda Y, Yamamoto K, Hirano S, Satoi S, Matsumoto I, Takahashi S, Morinaga S, Yoshida M, Sakuma Y, Iwamoto H, Shimizu Y, Uesaka K

Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC04)

Satoi S, Kimura Y, Shimizu R, Matsumoto M, Kawagchi K, Yoshida Y, Murase T, Kamei K, Matsumoto I, Nakai T, Takeyama Y

Gastrectomy reduces pancreatic secretory function via pancreatic atrophy.

Nanno Y, Toyama H, Ueshima E, Sofue K, Matsumoto I, Ishida J, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Kuramitsu K, Goto T, Asari S, Yanagimoto H, Kido M, Ajiki T, Fukumoto T

Transarterial chemoembolization for liver metastases of a pancreatic neuroendocrine neoplasm: a single-center experience.

Nakamura I, Hatano E, Baba H, Kamei K, Wada H, Shimizu J, Kanai M, Yoshimura K, Nagano H, Ioka T

Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer

Takada A, Sasaki M, Ueno H, Goto T, Murohisa G, Mizuno N, Ozaka M, Kobayashi S, Uesugi K, Kobayashi N, Hayashi H, Sudo K, Okano N, Horita Y, Kamei K, Nanami S, Boku N

FOLFIRINOX in pancreatic cancer: Risk factors for febrile neutropenia and severe neutropenia – Nationwide study analysis

Hozaka Y, Ohtsuka T, Nakamura M, Hijioka S, Unno M, Shimizu Y, Tanabe M, Nagakawa Y, Hatano E, Kawai M, Sano T, Koshita S, Katanuma A, Kita E, Hanada K, Nakai Y, Aoki T, Serikawa M, Okamoto K, Takeyama Y

Feasibility of surveillance for mucinous cystic neoplasm of the pancreas: a multi-institutional retrospective study of 328 patients by the Japanese Pancreatic Society

Kudo M, Aoki T, Ueshima K, Tsuchiya K, Morita M, Chishina H, Takita M, Hagiwara S, Minami Y, Ida H, Nishida N, Ogawa C, Tomonari T, Nakamura N, Kuroda H, Takebe A, Takeyama Y, Hidaka M, Eguchi S, Chan SL, Kurosaki M, Izumi N

Achievement of complete response and drug-free status by Atezolizumab plus Bevacizumab combined with and without curative conversion in patients with transarterial chemoembolization-unsuitable, imtermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study

Tomimaru Y, Eguchi H, Shimomura Y, Kitamuta T, Inoue Y, Nagakawa Y, Oba A, Onoe S, Unnno M, Hashimoto D, Kawakatsu S, Hayashi T, Higuchi R, Kitagawa H, Uemura K, Kimura Y, Satoi S, Takeyama Y; Committee of Clinical Research, Japan Pancreatic Society

Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreatic Society

Kin T, Shimizu Y, Hijioka S, Hara K, Katanuma Y, Nakamura M, Yamada R, Itoi T, Ueki T, Masamune A, Hirono S, Koshita S, Hanada K, Kamata K, Yanagisawa A, Takeyama Y

A comparative study between computed tomography and endoscopic ultrasound in the detection of a mural nodule in intraductal papillary mucinous neoplasm-multicenter observational study in Japan

Kozawa Y, Yamamoto A, Nakakuki M, Fujiki K, Kondo S, Okada T, Fukuyasu T, Yamaguchi M, Taniguchi I, Nomura N, Liu L, Higuchi M, Niwa E, Sohma Y, Naruse S, Takeyama Y, Ishiguro H

Clinical and genetic features of cystic fibrosis in Japan

Fujita N, Yasuda I, Endo I, Isayama H, Iwashita T, ueki T, Uemura K, Umezawa A, Katanuma A, Katayose Y, Suzuki S, Shoda J, Tsuyuguchi T, Wakai T, Inui K, Unno M, Takeyama Y, Itoi T, Koike K, Mochida S

Evidence-based clinical practice guidelines for cholelithiasis 2021

Nomi T, Kaibori M, Tanaka S, Hirokawa F, Hokuto D, Noda T, Ueno M, Nakai T, Ikoma H, Iida H, Matsui K, Komeda K, Hayami S, Eguchi H, Matsumoto M, Morimura R, Maehira H, Yoshikawa T, Kubo S

Short- and long-term outcomes of laparoscopic versus open repeat liver resection for hepatocellular carcinoma: A multicenter study

Tanaka S, Noda T, Komeda K, Kosaka H, Iida H, Ueno M, Hokuto D, Ikoma H, Nakai T, Kabata D, Shinkawa H, Kobayashi S, Hirokawa F, Mori H, Hayami S, Morimura R, Matsumoto M, Ishizawa T, Kubo S, Kaibori M

Surgical outcomes for hepatocellular carcinoma in patients with Child-Pugh Class B: a retrospective multicenter study

Ota M, Komeda K, Iida HO, Ueno M, Kosaka H, Nomi T, Tanaka S, Nakai T, Hokutou D, Matsumoto M, Hirokawa F, Lee SW, Kaibori M, Kubo S

The prognostic value of preoperative serum markers and risk classification for patients with hepatocellular carcinoma

Ota M, Komeda K, Iida HO, Ueno M, Kosaka H, Nomi T, Tanaka S, Nakai T, Hokutou D, Matsumoto M, Hirokawa F, Lee SW, Kaibori M, Kubo S

ASO Visual Abstract: The prognostic value of preoperative serum markers and risk classification for patients with hepatocellular carcinoma

Nomi T, Kaibori M, Hirokawa F, Ueno M, Hokuto D, Noda T, Nakai T, Ikoma H, Iida H, Kubo S

Effect of laparoscopic liver resection on postoperative delirium in elderly patients with hepatocellular carcinoma

Shinkawa H, Kaibori M, Kabata D, Nakai T, Ueno M, Hokuto D, Ikoma H, Iida H, Komeda K, Tanaka S, Kosaka S, Nobori C, Hayami S, Yasuda S, Morimura R, Mori H, Kagota S, Kudo S, Ishizawa T

Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach

Hirota M, Itoi T, Morizane T, Koiwai A, Yasuda I, Ryozawa S, Mukai S, Ikeura T, Irisawa A, Iwasaki E, katanuma A, Kitamura K, Takenaka M, Ito T, Masamune A, Mayumi T, Takeyama Y

Post-procedure serum amylase or lipase levels predict post-endoscopic retrograde cholangiography pancreatitis: a meta-analysis of diagnostic test accuracy studies and utility assessment

Imamura S, Niwano F, Babaya N, Hiromine Y, Matsumoto I, Kamei K, Yoshida Y, Taketomo Y, Yoshida S, Takeyama Y, Noso S, Maeda N, Ikegami H

High incidence of diabetes mellitus after distal pancreatectomy and its predictors: A long-term follow up study

Bodegraven EA, Lof S, Jones L, Aussihou B, Yong G, Jishu W, Klotz R, Rocha-Castellaneos DM, Matsumoto I, de Ponthaud C, Tanaka K, Biesel E, Kauffmann, Dumitrascu T, Nagakawa Y, Marti-Cruchaga P, Roeyen G, Zerbi A, Goetz M, de Meijer V, Pissaux P, Ignatavicus P, Demir I, Giuffrida M, Tingstedt B, Marino MV, Mastoridis S, Brunner M, Mora-Oliver I, Bortolato C, Gulla A, Apers T, Hermand H, Mitsuka Y, Popescul I, Boggi U, Wittel U, Hirano S, Gaujoux S, Kamei K, Fernandez-Del Castillo C, Hackert T, Kuirong J, Yi M, Sauvanet A, Besselink M, Abu Hilal M, Dokmak S; European Consortium on Minimally Invasive Pancreatic Surgery and International Consortium on Minimally Invasive Pancreatic Surgery

Tailoring the use of central pancreatectomy through prediction models for major morbidity and postoperative diabetes: International retrospective multicenter study

PancreasGroup.org Collaborative

Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries